Skip to content
  • Tuesday, 25 August 2026
  • 1:07 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
Laboratory Automation & Robotics

How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform

Lana Keisha Jul 23, 2026 0

More than a decade ago, the American Society of Clinical Oncology (ASCO) initiated CancerLinQ, a pioneering platform designed with the…

Read More
Laboratory Automation & Robotics

How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform

Lana Keisha Jul 16, 2026 0

Over a decade ago, the American Society of Clinical Oncology (ASCO) initiated a groundbreaking endeavor with the launch of CancerLinQ,…

Read More
Laboratory Automation & Robotics

How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform

Lana Keisha Jul 9, 2026 0

In a significant advancement for precision oncology, ConcertAI, a leading AI and real-world data company focused on cancer care, has…

Read More
Federal University of Technology Owerri Researchers Identify Water-in-Diesel Emulsion as a Sustainable Solution for Global Engine Emission Reduction3D-Printed Ceramic Implants Mimic Natural Bone, Offering Safer Alternative to GraftsBiomarker Battles: Clinicians Champion Surrogate Endpoints Amidst Regulatory CautionScience News: A Century of Empowering Public Understanding of Science
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ